C57BL/6N-Atm1Brd Nbeal2tm1a(EUCOMM)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:06100 |
International strain name | C57BL/6N-Atm1Brd Nbeal2tm1a(EUCOMM)Wtsi/WtsiCnbc |
Alternative name | EPD0598_2_C01 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Nbeal2tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Nbeal2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0598_2_C01. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Disease and phenotype information
MGI allele-associated human disease models
Orphanet associated rare diseases, based on orthologous gene matching
- Gray platelet syndrome / Orphanet_721
IMPC phenotypes (allele matching)
MGI phenotypes (allele matching)
- abnormal megakaryocyte differentiation / MGI
- enlarged spleen / MGI
- decreased metastatic potential / MGI
- increased inflammatory response / MGI
- abnormal megakaryocyte morphology / MGI
- increased mean platelet volume / MGI
- thrombocytopenia / MGI
- abnormal platelet shape / MGI
- abnormal platelet morphology / MGI
- myelofibrosis / MGI
- decreased platelet alpha-granule number / MGI
MGI phenotypes (gene matching)
- decreased neutrophil cell number / MGI
- abnormal megakaryocyte differentiation / MGI
- enlarged spleen / MGI
- decreased metastatic potential / MGI
- impaired wound healing / MGI
- increased inflammatory response / MGI
- abnormal megakaryocyte morphology / MGI
- abnormal blood coagulation / MGI
- increased mean platelet volume / MGI
- thrombocytopenia / MGI
- abnormal platelet shape / MGI
- abnormal platelet morphology / MGI
- abnormal response to injury / MGI
- increased bleeding time / MGI
- decreased cerebral infarction size / MGI
- abnormal platelet activation / MGI
- increased megakaryocyte cell number / MGI
- decreased platelet aggregation / MGI
- myelofibrosis / MGI
- impaired myofibroblast differentiation / MGI
- enhanced megakaryocyte emperipolesis / MGI
- decreased platelet alpha-granule number / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).